Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently completed a Phase 3 clinical ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

Pfizer set about evaluating inclacumab in pair of phase 3 studies, dubbed Thrive. The Big Pharma terminated one of those ...

Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.

SELLAS Life Sciences is developing GPS as a WT1 immunotherapy, which is in Phase 3 for AML. Click here to read why SLS stock ...

Pegozafermin, ETNB's FGF21 analog, shows promise in late-stage trials for MASH & severe hypertriglyceridemia. Key data & ...

IO Biotech’s cancer vaccine has “narrowly” failed to beat Merck's blockbuster oncology drug Keytruda in a phase 3 melanoma ...

"We’ve got to this point through cooperation and perseverance, and we will use that same approach to overcome the challenges ...

In this ongoing phase 3, multicenter, randomized, double-blind, placebo-controlled trial, we assigned 1197 patients with biopsy-defined MASH and fibrosis stage 2 or 3 in a 2:1 ratio to receive ...

Phase 3 Marketing and Communications has acquired Technology Media Group (TMG), marking its 11th acquisition. TMG’s capabilities will strengthen Phase 3’s fabrication, embroidery, and branded ...

Phase 3, the phase that began on Wednesday, is where the fun starts, which is why we get to watch. In these next four weeks, teams are allowed to conduct 10 days of organized team activities (OTAs).